News and Views
Nature Immunology 10, 235 - 236 (2009)
doi:10.1038/ni0309-235
Deciding the decider: Mef2c in hematopoiesis
Rachel M Gerstein1
-
Rachel M. Gerstein is in the Department of Molecular Genetics and Microbiology, Graduate Program in Immunology/Virology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.
e-mail: rachel.gerstein@umassmed.edu
Abstract
Factors influencing progenitor cell 'choice' between lymphoid and myeloid lineage fates are incompletely understood. New work implicates the transcription factor Mef2c as one component needed to promote lymphoid and suppress myeloid lineage differentiation.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Immunology Blood lines redrawnNature News and Views (10 Apr 2008)
To T or not to T: reassessing the common lymphoid progenitorNature Immunology News and Views (01 Feb 2003)
See all 3 matches for News And ViewsRESEARCH
Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2cNature Immunology Article (01 Mar 2009)
Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5Nature Immunology Article (01 Feb 2008)
See all 11 matches for Research
